Sign inJoin waitlistJoin the waitlist

Archna Bajaj

Director, Clinical Trials · Penn Medicine Center for Preventive Cardiology and Lipid Management

Credentials: · · · · ·

History

University of Pennsylvania Health System
Present
University of Pennsylvania Perelman School of Medicine
Present

Cardiovascular Disease
2021–2024
University of Pennsylvania
2020–2021
University of Pennsylvania
2018–2020
University of Pennsylvania
2017
Internal Medicine
Temple University Hospital
2012–2015
Case Western Reserve University School of Medicine
2008–2012
Union College
2005
Union College
2004

Research

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
Review · Journal of clinical lipidology · 2024 · 262 citations
Parkinson's disease and cancer risk: a systematic review and meta-analysis
Systematic review or meta-analysis · Cancer Causes & Control · 2010 · First of 3 authors · Corresponding · 207 citations
Shift Work, Chronotype, and Melatonin Rhythm in Nurses
Cancer Epidemiology · 2019 · 112 citations

Daniel Rader
11 papers
Daniel Soffer
4 papers
Mahboob Rahman
3 papers
Scott Damrauer
3 papers · 2 as a fellow
Alan Go
2 papers
Douglas Jacoby
2 papers
Joshua Denny
2 papers
Katalin Susztak
2 papers
Michael Wilkinson
2 papers
Pam Taub
2 papers
Robert Rosenson
2 papers
AS
Aeron Small
1 paper · 1 as a resident

Clinical trials

Investigating the Effect of Obicetrapib on Lipoprotein Metabolism
Principal investigator · Active not recruiting · Phase 1
NewAmsterdam Pharma
2023–2024
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2026–2030
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2031
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
Site PI · Recruiting · Phase 2
NewAmsterdam Pharma
2024–2027